The role of iron in hepatitis C infection

被引：0

作者：

Tusar K. Desai

Jared Bortman

Rasm Al-Sibae

Herbert Bonkovsky

机构：

[1] Department of Internal Medicine, William Beaumont Hospital, Royal Oak, MI

[2] Carolinas Medical Center, Charlotte, NC

来源：

Current Hepatitis Reports | 2012年 / 11卷 / 1期

关键词：

Hepatitis C; Iron; Iron overload;

D O I：

10.1007/s11901-011-0120-4

中图分类号：

学科分类号：

摘要：

Iron overload of varying degrees is common among patients with chronic hepatitis C. The clinical significance of this iron overload is uncertain. Studies that have evaluated the effect of hepatic iron stores on the response to anti-viral treatment or on the natural history of chronic hepatitis C have found variable results depending on the technique used to measure hepatic iron stores and the degree of iron overload present among the study population. We have tried to comprehensively analyze the literature regarding the clinical interaction between iron overload and the natural history of chronic hepatitis C. The one clear relationship that emerges is that pre treatment serum ferritin inversely correlates with the odds of achieving sustained virological(SVR) response after combination interferon ri-bavirin treatment. We have also reviewed the limited literature that reports the effect of therapeutic phlebotomy to reverse iron overload among patients with chronic hepatitis C. A small meta-analysis of 6 prospective randomized trials and a subsequent seventh trial do suggest that phlebotomy to induce iron depletion enhances the likelihood of achieving (SVR) after anti-viral therapy. However, these studies are primarily in patients receiving interferon monotherapy, which is of course now obsolete. Finally, a few small studies suggest that therapeutic phlebotomy to induce iron depletion reduces liver transaminase levels and may improve histology, and perhaps even reduce the risk of hepato-cellular carcinoma. Prospective randomized controlled trials of phlebotomy among patients with advanced hepatitis C and iron overload are needed. © 2012 Springer Science+Business Media, LLC.

引用

页码：41 / 47

页数：6

共 40 条

[1]

Di Bisceglie A.M., Axiotis C.A., Hoofnagle J.H., Bacon B.R., Measurements of iron status in patients with chronic hepatitis, Gastroenterology, 102, pp. 2108-2113, (1992)

[2]

Tung B.Y., Emond M.J., Bronner M.P., Raaka S.D., Cotler S.J., Kowdley K.V., Hepatitis C, iron status, and disease severity: Relationship with HFE mutations, Gastroenterology, 124, 2, pp. 318-326, (2003)

[3]

Nishina S., Hino K., Korenaga M., Vecchi C., Pietrangelo A., Mizukami Y., Furutani T., Sakai A., Okuda M., Hidaka I., Okita K., Sakaida I., Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription, Gastroenterology, 134, 1, pp. 226-238, (2008)

[4]

Van Thiel D.H., Friedlander L., Fagiuoli S., Wright H.I., Irish W., Gavaler J.S., Response to interferon α therapy is influenced by the iron content of the liver, Journal of Hepatology, 20, 3, pp. 410-415, (1994)

[5]

Olynyk J.K., Reddy K.R., Di Bisceglie A.M., Et al., Hepatic iron concentration as a predictor of response to interferon-alfa therapy in chronic hepatitis C, Gastroenterology, 108, pp. 1104-1109, (1995)

[6]

Fargion S., Fracanzani A.L., Sampietro M., Molteni V., Boldorini R., Mattioli M., Cesana B., Lunghi G., Piperno A., Valsecchi C., Fiorelli G., Liver iron influences the response to interferon alpha therapy in chronic hepatitis C, European Journal of Gastroenterology and Hepatology, 9, 5, pp. 497-503, (1997)

[7]

Piperno A., Sampietro M., D'Alba R., Roffi L., Fargion S., Parma S., Nicoli C., Corbetta N., Pozzi M., Arosio V., Boari G., Fiorelli G., Iron stores, response to α-interferon therapy, and effects of iron depletion in chronic hepatitis C, Liver, 16, 4, pp. 248-254, (1996)

[8]

Ikura Y., Morimoto H., Johmura H., Fukui M., Sakurai M., Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C, American Journal of Gastroenterology, 91, 7, pp. 1367-1373, (1996)

[9]

Rulyak S.J., Eng S.C., Patel K., McHutchison J.G., Gordon S.C., Kowdley K.V., Relationships between hepatic iron content and virologic response in chronic hepatitis C patients treated with interferon and ribavirin, American Journal of Gastroenterology, 100, 2, pp. 332-337, (2005)

[10]

Hofer H., Osterreicher C., Jessner W., Penz M., Steindl-Munda P., Wrba F., Ferenci P., Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C, Journal of Hepatology, 40, 6, pp. 1018-1022, (2004)

← 1 2 3 4 →